Immune Response and Restoration: Where Are We Now; Where Are We Going?

PROGRAM OVERVIEW
The use of HAART has revolutionized the management of HIV/AIDS and reduced the rates of mortality and morbidity
resulting from HIV infection. Currently, one focus of scientists and researchers has been the determination of the process
by which HAART can assist immune reconstitution. This meeting will bring together international experts to discuss the
questions surrounding this issue.
TARGET AUDIENCE
Healthcare providers registered to attend the XIV International AIDS Conference in Barcelona, Spain.
EDUCATIONAL OBJECTIVES
Upon completion of the program, participants should be able to:

* Identify the effects of HAART on immune reconstitution
* Recognize the process utilized by the immune system
to control HIV
* Describe the role of T cells in the immunological
response to HIV

* Explain the clinical efficacy of interleukin-2 therapy on
T-cell function
* Distinguish between the various immunological approaches
to HIV therapy

ACCREDITATION
The NYU Post-Graduate Medical School is accredited by the Accreditation Council for Continuing Medical Education
(ACCME) to sponsor continuing medical education for physicians.
The NYU Post-Graduate Medical School designates this continuing medical education activity for 2 credit hours in
Category 1 of the Physician's Recognition Award of the American Medical Association.
The NYU Post-Graduate Medical School adheres to ACCME standards regarding industry support of continuing medical
education. Disclosure of any commercial relationships as well as the discussion of off-label or investigational use of any
drug, device or procedure by the faculty will be made known at the symposium.
FACULTY

CME COURSE DIRECTOR
Michael L. Tapper, MD
Chief, Section of Infectious Diseases
Medical Director, AIDS Program
Lenox Hill Hospital
New York, NY
Bonaventura Clotet, MD, PhD
Head, Retrovirology Laboratory of
irsiCaixa Foundation
Head, HIV Unit of Hospital Universitari
Germans Trias i Pujol
Barcelona, Spain
David A. Cooper, MD, DSc
Professor of Medicine
Director, National Centre in HIV
Epidemiology and Clinical Research
St. Vincent's Hospital Medical Centre
University of New South Wales
Sydney, Australia

Mette Hazenberg, MD
Sanquin Research at CLB
Department of Clinical
Viro-Immunology
Amsterdam, The Netherlands
Yves L6vy, MD, PhD
Professeur
Hipital Henri Mondor
Unite D'lmmunologie Clinique
Cr6teil Cedex, France
Giuseppe Pantaleo, MD
Chief of Laboratory
Centre Hospitalier
Lausanne, Switzerland

Giuseppe Tambussi, MD
Head, Experimental Therapies Unit
Clinic of Infectious Diseases
San Raffaele Scientific Institute
Milano, Italy
Bruce D. Walker, MD
Professor of Medicine
Harvard Medical School
Director, Partners AIDS
Research Center
Boston, Massachusetts

AGENDA

Welcome and Introduction
David A. Cooper, MD, DSc
Program Co-chairman
Successes and Limitations of
HAART on immune Reconstitution
Bonaventura Clotet, MD, PhD
Immune Control of HIV
Giuseppe Pantaleo, MD

T-cell Dynamics in HIV Disease
Mette Hazenberg, MD
Discussion
David A. Cooper, MD, DSc
Effects of IL-2 Therapy on
T-cell Function in HIV
Yves Levy, MD, PhD

Immunological Approaches
to HIV Therapy
Bruce D. Walker, MD
Discussion
Giuseppe Tambussi, MD
Program Co-chairman
Closing Remarks
Giuseppe Tambussi, MD